<?xml version="1.0" encoding="UTF-8"?>
<p>Human colon cancer cells HT-29 were grown in McCoy 5A medium supplemented with 10% (
 <italic>v</italic>/
 <italic>v</italic>) fetal bovine serum (FBS) and 1% (
 <italic>v</italic>/
 <italic>v</italic>) penicillin-streptomycin, while mouse Colon26-Luc cells were grown in RPMI 1640 medium supplemented with 2 mM L-glutamine, 10% (
 <italic>v</italic>/
 <italic>v</italic>) FBS and 1% (
 <italic>v</italic>/
 <italic>v</italic>) penicillin-streptomycin. Cells were kept in culture flasks in a humidified incubator with 5% CO
 <sub>2</sub> at 37 °C. Cells were detached by trypsinization with trypsin-EDTA (0.25%) when they reached 80 % confluence and subcultured every 3–5 days. Cells (5 × 10
 <sup>3</sup>/well) were seeded into 96-well plates and incubated overnight, then treated with different concentrations of tricin (50–400 μM) for 24 or 48 h. Cell viability was measured using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay [
 <xref rid="B44-molecules-25-03730" ref-type="bibr">44</xref>].
</p>
